Nucleoside

Results: 353



#Item
241Information for Inuit Community Members Fact Sheet 3 HIV/AIDS -Treatment NEVIRAPINE What is Nevirapine? Nevirapine is one medicine that is part of a large family of drugs usually called Non-nucleosides

Information for Inuit Community Members Fact Sheet 3 HIV/AIDS -Treatment NEVIRAPINE What is Nevirapine? Nevirapine is one medicine that is part of a large family of drugs usually called Non-nucleosides

Add to Reading List

Source URL: pauktuutit.ca

Language: English - Date: 2012-10-31 13:54:39
242August I,[removed]IMPORTANT PRESCRIBING INFORMATION / RE: Revised prescribin,0 information regarding the preferred twice-daily dosing for VIDEX@ (didanosine) based on new study results Dear Healthcare Provider,

August I,[removed]IMPORTANT PRESCRIBING INFORMATION / RE: Revised prescribin,0 information regarding the preferred twice-daily dosing for VIDEX@ (didanosine) based on new study results Dear Healthcare Provider,

Add to Reading List

Source URL: www.fda.gov

Language: English
243Kentucky Department for Medicaid Services Drug Management Review Advisory Board (DMRAB) Recommendations for Consideration The following chart provides a summary of the recommendations that were made by the Drug Managemen

Kentucky Department for Medicaid Services Drug Management Review Advisory Board (DMRAB) Recommendations for Consideration The following chart provides a summary of the recommendations that were made by the Drug Managemen

Add to Reading List

Source URL: chfs.ky.gov

Language: English - Date: 2014-08-21 13:53:03
244AIDS InfoNet  www.aidsinfonet.org Fact Sheet Number 001A

AIDS InfoNet www.aidsinfonet.org Fact Sheet Number 001A

Add to Reading List

Source URL: aidsinfonet.org

Language: English - Date: 2013-09-05 09:42:15
245Organic chemistry / Gilead Sciences / Organofluorides / Cyclopropanes / Non-nucleoside reverse transcriptase inhibitors / Antiretroviral drug / Reverse-transcriptase inhibitor / Emtricitabine / AIDS / HIV/AIDS / Chemistry / Medicine

AIDS InfoNet www.aidsinfonet.org Fact Sheet Number 001A

Add to Reading List

Source URL: aidsinfonet.org

Language: English - Date: 2013-09-05 09:42:15
246Supplements 11, 12, & 14 draft labeling  HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INTELENCE® safely and effectively. See full prescribing information for IN

Supplements 11, 12, & 14 draft labeling HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INTELENCE® safely and effectively. See full prescribing information for IN

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2013-03-01 14:46:34
247Global HIV Access & Partnerships Program GAPP Status: Branded Registration Efforts AT JANSSEN, a comprehensive, multi-country registration effort ensures timely availability of our branded HIV medicines where there is a

Global HIV Access & Partnerships Program GAPP Status: Branded Registration Efforts AT JANSSEN, a comprehensive, multi-country registration effort ensures timely availability of our branded HIV medicines where there is a

Add to Reading List

Source URL: www.janssenrnd.com

Language: English - Date: 2012-07-18 12:13:42
2481  HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INTELENCE® safely and effectively. See full prescribing information for INTELENCE®.

1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INTELENCE® safely and effectively. See full prescribing information for INTELENCE®.

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2012-08-15 16:02:38
249

PDF Document

Add to Reading List

Source URL: hab.hrsa.gov

Language: English - Date: 2012-01-06 21:03:00
25022187 Etravirine Clinical PREA

22187 Etravirine Clinical PREA

Add to Reading List

Source URL: www.fda.gov

Language: English